Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
APSC Consensus Recommendations on Dyslipidaemia
Author(s): Natalie Koh , Brian Ference , Stephen J Nicholls , et al Added: 2 years ago

Standards & Guidelines

Prevention & Chronic Conditions
ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights
Author(s): Michelle Kittleson Added: 1 year ago
Dr Michelle Kittleson (Cedars-Sinai California Heart Center, US) provides an overview of the 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient with Cardiac Amyloidosis.Dr Kittleson highlights the unmet needs in managing patients with cardiac amyloidosis and stresses the importance of a multidisciplinary approach involving cardiologists,… View more

Standards & Guidelines

Heart Failure
APSC Consensus for Pre-participation Screening in Young Competitive Athletes
Author(s): Luokai Wang , Tee Joo Yeo , Benedict Tan , et al Added: 2 years ago

Electrophysiology & Arrhythmia
APSC Consensus Recommendations for MitraClip in MR
Author(s): Khung Keong Yeo , Jack Wei Chieh Tan , David WM Muller , et al Added: 2 years ago

Intervention
APSC Consensus Recommendations on High-risk Chronic Coronary Syndrome
Author(s): Jack Wei Chieh Tan , Derek P Chew , David Brieger , et al Added: 2 years ago

Anticoagulation

Prevention & Chronic Conditions
APSC Consensus on Optimising CV Outcomes in T2D
Author(s): Jack Wei Chieh Tan , David Sim , Junya Ako , et al Added: 2 years ago

Standards & Guidelines

Prevention & Chronic Conditions
2020 APSC Consensus Recommendations on P2Y12 Inhibitor Use
Author(s): Jack Wei Chieh Tan , Derek P Chew , Muhamad Ali SK Abdul Kader , et al Added: 3 years ago

Anticoagulation

Standards & Guidelines
P2Y12 Inhibitors for Special Populations in the Asia-Pacific Region
Author(s): Jack Wei Chieh Tan , Derek P Chew , Kin Lam Tsui , et al Added: 2 years ago

Vascular Disease and Surgery

MI/ACS
APSC Consensus on OSA in CVD Patients
Author(s): Jack Wei Chieh Tan , Leong Chai Leow , Serene Wong , et al Added: 1 year ago

Prevention & Chronic Conditions

CV Disease in Special Populations
Author(s): Kristian Rivera , Cristina Marzo , Nuria Sans , et al Added: 3 years ago
Topic: 1. Clinical Cardiology Introduction Universal use of Direct Oral Anticoagulants (DOACs) in non-valvular atrial fibrillation (nVAF) is not possible for economic reasons. It is necessary to prescribe them to those patients with greater potential benefit. The best way to achieve this objective is the application of a territorial protocol, designed and accepted by all professionals… View more

Heart Failure

Electrophysiology & Arrhythmia